Corient Private Wealth
PFE icon

Corient Private Wealth’s Pfizer PFE Stock Holding History

Corient Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3M Sell
2,547,672
-10,757
-0.4% -$281K 0.08% 209
2026
Q1 		$71.5M Sell
2,558,429
-271,294
-10% -$7.22M 0.1% 181
2025
Q4 		$70.5M Sell
2,829,723
-84,712
-3% -$2.14M 0.1% 195
2025
Q3 		$74.3M Buy
2,914,435
+859,861
+42% +$21.2M 0.12% 177
2025
Q2 		$49.8M Sell
2,054,574
-179,789
-8% -$4.19M 0.07% 231
2025
Q1 		$56.6M Sell
2,234,363
-403,344
-15% -$10.6M 0.09% 206
2024
Q4 		$69.3M Sell
2,637,707
-484,914
-16% -$13.2M 0.12% 179
2024
Q3 		$90.4M Sell
3,122,621
-320,187
-9% -$9.34M 0.14% 152
2024
Q2 		$96.3M Sell
3,442,808
-19,504
-0.6% -$537K 0.17% 136
2024
Q1 		$96.1M Buy
3,462,312
+19,478
+0.6% +$540K 0.17% 137
2023
Q4 		$99.1M Buy
3,442,834
+279,095
+9% +$8.44M 0.18% 127
2023
Q3 		$105M Buy
3,163,739
+25,534
+0.8% +$903K 0.24% 100
2023
Q2 		$115M Buy
3,138,205
+452,030
+17% +$17.6M 0.27% 94
2023
Q1 		$110M Buy
2,686,175
+377,547
+16% +$16.3M 0.29% 83
2022
Q4 		$118M Buy
+2,308,628
New +$111M 0.43% 61

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Corient Private Wealth's PFE Position: Q2 2026 in Review

Corient Private Wealth reduced its Pfizer (PFE) stake by 0.42% in Q2 2026, selling an estimated $281K and leaving 2,547,672 shares worth $61.3M. The position accounts for 0.08% of the portfolio, ranked #209.

Corient Private Wealth first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $118M in Q4 2022. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Corient Private Wealth held 2,547,672 shares of Pfizer worth $61.3M as of Q2 2026.
  • Corient Private Wealth sold 10,757 Pfizer shares in Q2 2026, an estimated $281K.
  • Pfizer made up 0.08% of Corient Private Wealth's portfolio in Q2 2026, its #209 holding.
  • Corient Private Wealth first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Pfizer position peaked at $118M in Q4 2022.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.